This early reduction is a positive indicator of the potential for further weight loss with continued use of the medication
That makes it the single largest addressable market for incretin therapies, and domestic competition is intensifying fast
The causality is unclear, and confounding factors are significant, but it raises a flag that needs further investigation
December 2024 Telehealth provider Ro expanded its GLP-1 weight loss platform to include Zepbound , offering virtual consultations and insurance support across all 50 U.S
Bulls would counter that volume grew 65%, more than offsetting price declines, and IPR&D charges reflect investment in tomorrows pipeline rather than core profit erosion
When food enters the small intestine, GLP-1 is released, stimulating the pancreas to secrete insulin, the hormone responsible for lowering blood sugar